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BACKGROUND:  Blood  histamine  levels  are  decreased
after severe allergic reactions and in various chronic
diseases.
Aims: To study blood histamine levels in infants and
children  with  acute  infectious  and  non-infectious,
non-allergic, disease.
Methods: Blood histamine levels were investigated by
a fluorometric method in infants and children admit-
ted  to  hospital  with  bronchiolitis,  non-wheezing
bronchitis, acute infections of the urinary tract, skin
and  earÐnoseÐthroat,  gastroenteritis,  or  hyperther-
mia of unknown aetiology. Results of blood histamine
levels  and  white  blood  cell  counts  were  compared
with  those  obtained  for  children  recovering  from
benign non-infectious, non-allergic illnesses.
Results:  As  compared  with  control  children,  white
blood  cell  numbers  were  significantly  increased  in
children  with  acute  infections  of  the  urinary  tract,
skin  and  earÐnoseÐthroat,  and  were  significantly
decreased  in  children  with  gastroenteritis.  Blood
histamine levels were significantly lower in children
with gastroenteritis and hyperthermia  than in chil-
dren with other diseases and control children. It was
not possible to correlate blood histamine levels and
the number of blood basophils.
Conclusions:  BHL  are  significantly  decreased  in
infants  and  children  with  acute  gastroenteritis  and
hyperthermia  of  unknown  aetiology.  The  mecha-
nisms  responsible  for  the  decrease  in  blood  hista-
mine  levels  in  children  with  gastroenteritis  and
hyperthermia are discussed.
Key  words:  Blood  histamine,  Bronchiolitis,  Bronchitis,
Gastroenteritis, Hyperthermia, Infant, Child
Introduction
Histamine  plays  an  important  role  in  physiological
homeostasis  and  in  the  pathogenesis  of  various
diseases via its regulatory effects on smooth muscle
contraction, vascular tone  and  permeability,  gastric
secretion, neurotransmission, the immune system and
inflammation.1,2
Plasma histamine  levels  (PHL)  increase in  patho-
logical  conditions  associated with  mast  cell  and/or
basophil  activation,  such  as  severe  atopic  dermati-
tis,3,4 exercise-induced asthma,5 severe asthma,6 food
allergy,7,8 anaphylaxis  and  anaphylactoid  reac-
tions,9–11 and in chronic, non allergic diseases, such
as  sickle  cell  anemia,12 chronic  renal  failure  and
nephrotic  syndrome,13 and  polytraumatized
patients.14 However,  PHL  determinations  are  very
dependent on sampling procedure and on short half-
life of histamine in plasma, leading to numerous false
positive and false negative results.15
In  humans,  blood  histamine  is  almost  entirely
contained in basophils,16–19 and whole blood hista-
mine levels (BHL) are closely related to the number of
circulating basophils.20 Thus, BHL are independent of
sampling  conditions.21 BHL  are  significantly
decreased  in  conditions  associated  with  massive
blood  basophil  degranulation,  such  as  anaphylaxis
and  anaphylactoid reactions,21 and in  chronic non-
allergic diseases, such as malignant solid tumours in
adults22 and infection with human immunodeficiency
virus (HIV) in infants and children.20
BHL have not been studied in infants and children
with acute infectious and non-infectious, non-allergic
diseases. We  therefore  investigated  BHL  in  infants
and  children  admitted  to  hospital  with  various
acute  infectious  diseases  or  hyperthermia  of
unknown  aetiology.  Results  were  compared  with
those obtained for  hospitalised children  recovering
from  acute  non-infectious,  non-allergic  benign
illnesses.
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Children
128 children (46F + 82 M) admitted to hospital for
acute illnesses were investigated. The children were
aged from 3 days to 32 months (mean: 14 months).
Children were classified according to diagnosis:
d group 1: bronchiolitis;
d group 2: non-wheezing bronchitis;
d group  3:  infections  of  the  urinary  tract, skin, or
ear–nose–throat (ENT);
d group 4: acute gastroenteritis (GE);
d group  5:  transient  hyperthermia  of  unknown
aetiology;
d group  6  (controls):  children  recovering  from
benign non-infectious, non-allergic conditions such
as faintness, crying, oedema of unknown aetiology,
difficult bottle-feeding, spasms, and gastroesopha-
geal reflux.
The demographic characteristics of the children are
shown in Table 1.
Histamine determination and blood cell counts
Blood samples for white blood cell (WBC) counts and
BHL determination were taken at the same time as for
other  tests  (e.g.  electrolyte  determination),  after
informed consent has been obtained from the parents
of the children.
To take into account possible diurnal variations in
BHL,23 blood  was  always  taken  between  9.00  and
11.00h and treated as described previously.22 Briefly,
800 m g  0.15M NaCl and 1ml  0.8N perchloric  acid
were added to 200 m l of heparinised venous blood.
The mixture was vigourously shaken and centrifuged,
and  supernatants were  stored  in  polystyrene  tubes
until assay. Histamine was assayed using the fluoro-
metric  method  of  Shore  et  al.,24 automated  as
described by Siraganian and Brodsky,25 and modified
as described by Lebel.26The results were expressed as
nanograms of histamine base per millilitre blood (ng/
ml: mean±SEM).
The non  parametric test  of  Mann  & Whitney (U
test) was used for statistical analysis.
Results
Mean BHL and WBC counts for each group of children
are shown in Table 1. BHL were significantly lower in
children with GE and hyperthermia (p = 0.01) than in
control  children.  No  significant  differences  were
observed  between  control  children  and  the  other
groups  of  children. BHL  did not differ  significantly
between boys and girls (Table 2), and were independ-
ent of age (Table 3).
WBC numbers  were not significantly  different  in
control children and in  children with bronchiolitis,
bronchitis,  and  hyperthermia.  As  compared  with
control  children,  mean  number  of  WBC  was  sig-
nificantly increased in children with non-pulmonary
infections (p < 0.01), and was significantly decreased
in children with GE (p < 0.01). The number of blood
basophils  was  very  low,  and  below  the  detection
threshold in most of the children
Discussion
BHL are significantly correlated with the number of
circulating basophils,20 and decrease after the activa-
tion of blood basophils in patients with severe allergic
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Table 1. Characteristics  of  the infants and children, and results  of  blood histamine determinations and white blood  cell
counts
Group Children






1 29 20M + 9 F 1–10m (8m, 10d) 44.9 ± 24.4 13686 ± 5740
2 18 13M + 5 F 1–33m (13m, 1w) 53.8 ± 30.7 15483 ± 4876
3 15 8M + 7 F 1–26m (6m, 2w) 41.9 ± 17.6 17180 ± 9463*
4 24 16M + 8 F 10d–32m (8m) 19.6 ± 11.0* 10995 ± 4033*
5 16 8M + 8 F 1–36m (8m, 3w) 22.9 ± 6.8* 13125 ± 7148
6 26 17M + 9 F 3d–24m (5m, 3w) 53.3 ± 23.2 13869 ± 6313
Abbreviations: d (day),m (month), w (week).
Statistical significance assessed by the test of Mann & Whitney: *p<0.01 as compared with control children (group 6).
Table 2. Results  of  blood histamine determination (ng/ml:
mean±SEM) according to the sex of infants and children
Group Male Female
1 46.8 ± 26.4 42.7 ± 16.2
2 52.8 ± 33.1 56.6 ± 26.5
3 34.7 ± 9.1 48.2 ± 21.3
4 21.4 ± 12.7 15.9 ± 5.4
5 22.6 ± 5.6 23.1 ± 8.2
6 52.8 ± 13.1 53.5 ± 27.4reactions  such  as  anaphylaxis  and  anaphylactoid
reactions.21 We have also shown that BHL and blood
basophil  numbers  decrease  significantly  in  chronic
non-allergic  diseases  such  as  malignant  tumours  in
adults,22 and HIV infection in infants and children.20
The mechanisms involved in the decrease in BHL and
blood basophils in these patients are unknown. They
may be related to a chronic IgE-dependent activation
of  basophils by antigens from  HIV  and/or opportu-
nistic pathogens in HIV-infected patients,27–29 and to
the inhibition of basophil differentiation in the bone
marrow of tumour-bearing patients.22
In this study, we report the results of investigations
in infants and children with acute infectious and non-
infectious, non-allergic diseases. BHL in control chil-
dren  were  similar  to  those  reported  in  previous
studies,20 and were consistent with the blood baso-
phil  numbers  usually  found  in  infants  and  chil-
dren,30,31 and  with  the  reported  mean  histamine
content  of  blood  basophils.32 Our  results  are  con-
sistent with those of previous studies showing that
BHL  are  independent  of  age  and  sex  in  healthy
newborns, infants and children.20,33 WBC number in
control children was consistent with the total leuko-
cyte  numbers  usually  found  in  infants  and
children.31
BHL  did  not  differ  significantly  between  control
children and children with infections of the urinary
tract,  skin,  and  ENT,  non-wheezing  bronchitis  and
bronchiolitis.
Respiratory  viruses,  such  as  respiratory  syncytial
virus  (RSV),  induce Th2-type  immune  responses in
infected infants and children.34 Welliver et al. detec-
ted virus-specific IgE in the nasopharyngeal secretions
of  infants  infected  with  para-influenzae virus  and
RSV.35,36 Histamine levels are high in nasal secretions
of infants with RSV-induced bronchiolitis,36 and levels
of  virus-specific  IgE  and  histamine  are  significantly
and positively  correlated with the severity of bron-
chiolitis,  and  with  the  subsequent  development  of
wheezing.37,38 Although  virus-specific  IgE  are  pre-
dominantly  found  in  nasopharyngeal  secretions,37
they are also detected in the serum of RSV-infected
infants.39 Moreover, plasma histamine levels (PHL) are
high  in  infants  with  acute  bronchiolitis  and  in
children  with viral respiratory infections.40,41 How-
ever, the increase in  PHL reported in these studies
probably  results from histamine release due to IgE-
dependent  activation  of  bronchial  and  pulmonary
mast  cell  by  virus  antigens  because  we  found  no
convincing  evidence  for  in  vivo blood  basophil
activation in children with bronchiolitis, although in
vitro IgE-dependent activation of blood basophils by
viral  antigens  has  been  reported  in  RSV-infected
infants.42
BHL were normal in children with non-wheezing
bronchitis and infections  of  the  urinary  tract, skin,
and ENT. Most of these infections are due to viruses
(bronchitis)  and  bacteria (infections  of  the  urinary
tract,  skin,  and  ENT).  Mean  WBC  number  was
significantly increased in children with non broncho-
pulmonary  infections, consistent with  the bacterial
origin of the infections of the urinary tract, skin and
ear–nose–throat. With the exception of Mycoplasma
pneumoniae, which induces the production of spe-
cific IgE in  asthmatic patients,43 and other bacteria
such as Haemophilus influenzae and para-influen-
zae,  and  Pseudomonas  aeroginosa,  which  induce
mast cell activation in vivo,  and non-specific hista-
mine release in vitro,44 these pathogens induce an
inflammatory reaction, with no evidence of mast cell
and/or basophil activation.
BHL were significantly lower in children with GE
and hyperthermia than in control children. Unfortu-
nately,  it  was  not  possible  to  correlate  BHL  and
basophil  numbers  because  the  number  of  blood
basophils was very low, and often below the detection
threshold in most of the children. It has been shown
that  corticosteroid  treatment  causes  a  significant
decrease in BHL.16,23 However, most of the children in
our study, including children with hyperthermia and
gastroenteritis, were not treated with corticosteroids.
Moreover, we have previously shown that the decrease
in BHL and blood basophils in tumour-bearing patients
and in HIV-infected infants and children is significantly
and  inversely  correlated  with  the  severity  of  the
disease, and is independent of chemotherapy, radio-
therapy, and corticosteroids.20,22
Blood histamine levels in infants and children
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Table 3. Results of blood histamine determinations (ng/ml: mean±SEM) according to the age of
infants and children
Group <3 months 3–6 months >6 months
1 48.8 ± 25.1 54.1 ± 36.4 41.0 ± 15.6
2 64.5* 70.0 ± 14.2 48.5 ± 34.3
3 48.1 ± 21.7 ** 34.9 ± 7.9
4 23.5 ± 11.1 19.1 ± 14.5 17.7 ± 10.6
5 21.0 ± 5.8 26.7 ± 3.9 22.0 ± 7.4
6 46.4 ± 16.1 56.5 ± 33.2 63.6 ± 27.1
*2 infants only. **no child.Hyperthermia results from the release of mediators
and cytokines such as prostaglandin E2, endogenous
pyrogen,  interleukins  1,  6  and  8,  C-C chemokines,
tumour necrosis factor-a , and interferon-g .45,46 Most
of these cytokines also induce mast cell and basophil
activation,47–49 and  may  therefore  decrease  BHL.
However, WBC  numbers  did not differ  significantly
between  children  with  hyperthermia  and  control
children. Most children with hyperthermia recovered
spontaneously in a few days, suggesting that hyper-
thermia resulted from viral infection. However, most
cases of bronchiolitis, bronchitis and GE also resulted
from viral infections, and most of these children were
also hyperthermic at the time of BHL determination,
although fever was generally milder and/or of shorter
duration  in  these  children  than  in  children  with
hyperthermia of unknown aetiology.
In western countries, most cases of acute  GE  in
infants  and  children  result  from  viral  infections  of
the digestive tract, although a few  cases are attrib-
uted  to  bacteria,  such  as  enteropathogenic Escher-
ichia coli. Enteric viruses and bacteria induce major
inflammation  of  the  digestive  tract  mucosa,  asso-
ciated  with  large  losses  of  water  and  electrolytes,
and  with  a  transient malabsorption syndrome.  Pre-
vious  studies  have  shown  that  PHL  increase  sig-
nificantly  in  children with  acute GE,  but  return to
normal  after  recovery.50,51 The  authors  suggested
that  the  increase  in  PHL  resulted  from  mast  cell
activation in  the  intestine by  factors released from
the inflammed gut mucosa. The release of inflamma-
tory  mediators  from  the  digestive  tract,  known  to
recruit and activate basophils and mast cells, such as
complement  factors,52,53 factors  of  the  kinin  sys-
tem,54 and  chemokines,47–49,55–57 may  account  for
the  decrease  in  BHL  in  infants  and  children  with
acute  GE.  Preactivated human  basophils  have  also
been shown to release histamine and leukotriene C4
in  response to  stimulation with  secretory immuno-
globulin  A  (sIgA).58 As  sIgA  is  the  most  abundant
immunoglobulin isotype in gut mucosa and mucosal
secretions,  this  suggests  that  blood  basophils  are
recruited and activated in the digestive tract during
acute  GE.  However,  several other mechanisms may
also  be  involved:  (1)  IgE-dependent  activation  of
circulating  basophils  by  microbial  antigens.  How-
ever,  in  contrast  to  the  situation  for  bronchiolitis,
there are no reports concerning specific IgE against
enteric  pathogens  in  patients  with  GE.  (2)  Fever,
because  most  infants  and  children  with  GE  were
hyperthermic at the time of BHL determination (see
above).
Conclusion
BHL  decrease  significantly  in  infants  and  children
with  acute  gastroenteritis  and  hyperthermia  of
unknown  aetiology. The  mechanisms  involved,  and
the  possible  pathophysiological  significance  of  the
decrease in BHL in these diseases are unclear.
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